Samrvir Biotech Profile
Key Indicators
- Authorised Capital ₹ 7.38 M
as on 09-01-2025
- Paid Up Capital ₹ 7.38 M
as on 09-01-2025
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.61 Cr
as on 09-01-2025
- Satisfied Charges ₹ 2.38 Cr
as on 09-01-2025
- Revenue 59.22%
(FY 2024)
- Profit 31.32%
(FY 2024)
- Ebitda 183.75%
(FY 2024)
- Net Worth 27.86%
(FY 2024)
- Total Assets 24.13%
(FY 2024)
About Samrvir Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.38 M and a paid-up capital of Rs 7.38 M.
The company currently has active open charges totaling ₹4.61 Cr. The company has closed loans amounting to ₹2.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumant Kapoor and Preeti Kapoor serve as directors at the Company.
- CIN/LLPIN
U24303HR2019PTC082136
- Company No.
082136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Samrvir Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumant Kapoor  | Director | 21-Aug-2019 | Current |
| Preeti Kapoor | Director | 21-Aug-2019 | Current |
Financial Performance of Samrvir Biotech.
Samrvir Biotech Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 59.22% increase. The company also saw a substantial improvement in profitability, with a 31.32% increase in profit. The company's net worth Soared by an impressive increase of 27.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrvir Biotech?
In 2024, Samrvir Biotech had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Effikasia Lifesciences Private LimitedActive 4 years 2 monthsSumant Kapoor and Preeti Kapoor are mutual person
Raj Rasayana Herbals Private LimitedActive 19 years 7 monthsSumant Kapoor and Preeti Kapoor are mutual person
Charges (Loans)
₹46.10 M
₹23.80 M
Charges Breakdown by Lending Institutions
- Others : 4.33 Cr
- Hdfc Bank Limited : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2022 | Others | ₹3.50 M | Open |
| 24 Mar 2022 | Others | ₹3.98 Cr | Open |
| 10 Feb 2022 | Hdfc Bank Limited | ₹1.48 M | Open |
| 01 Feb 2021 | Hdfc Bank Limited | ₹1.30 M | Open |
| 11 Jul 2020 | Hdfc Bank Limited | ₹2.38 Cr | Satisfied |
How Many Employees Work at Samrvir Biotech?
Samrvir Biotech has a workforce of 131 employees as of Jan 09, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrvir Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrvir Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.